These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Cannabis for the Treatment of Epilepsy: an Update. Gaston TE; Szaflarski JP Curr Neurol Neurosci Rep; 2018 Sep; 18(11):73. PubMed ID: 30194563 [TBL] [Abstract][Full Text] [Related]
5. Voltage-gated sodium (NaV) channel blockade by plant cannabinoids does not confer anticonvulsant effects per se. Hill AJ; Jones NA; Smith I; Hill CL; Williams CM; Stephens GJ; Whalley BJ Neurosci Lett; 2014 Apr; 566():269-74. PubMed ID: 24642454 [TBL] [Abstract][Full Text] [Related]
6. Cannabidiol inhibits the skeletal muscle Nav1.4 by blocking its pore and by altering membrane elasticity. Ghovanloo MR; Choudhury K; Bandaru TS; Fouda MA; Rayani K; Rusinova R; Phaterpekar T; Nelkenbrecher K; Watkins AR; Poburko D; Thewalt J; Andersen OS; Delemotte L; Goodchild SJ; Ruben PC J Gen Physiol; 2021 May; 153(5):. PubMed ID: 33836525 [TBL] [Abstract][Full Text] [Related]
7. Cannabidiol and Sodium Channel Pharmacology: General Overview, Mechanism, and Clinical Implications. Ghovanloo MR; Ruben PC Neuroscientist; 2022 Aug; 28(4):318-334. PubMed ID: 34027742 [TBL] [Abstract][Full Text] [Related]
8. Molecular Targets of Cannabidiol in Neurological Disorders. Ibeas Bih C; Chen T; Nunn AV; Bazelot M; Dallas M; Whalley BJ Neurotherapeutics; 2015 Oct; 12(4):699-730. PubMed ID: 26264914 [TBL] [Abstract][Full Text] [Related]
9. A nutraceutical product, extracted from Cannabis sativa, modulates voltage-gated sodium channel function. Milligan CJ; Anderson LL; Bowen MT; Banister SD; McGregor IS; Arnold JC; Petrou S J Cannabis Res; 2022 Jun; 4(1):30. PubMed ID: 35689251 [TBL] [Abstract][Full Text] [Related]
10. Non-psychotropic phytocannabinoid interactions with voltage-gated sodium channels: An update on cannabidiol and cannabigerol. Ghovanloo MR; Dib-Hajj SD; Goodchild SJ; Ruben PC; Waxman SG Front Physiol; 2022; 13():1066455. PubMed ID: 36439273 [TBL] [Abstract][Full Text] [Related]
11. Advances and Challenges of Cannabidiol as an Anti-Seizure Strategy: Preclinical Evidence. Zavala-Tecuapetla C; Luna-Munguia H; López-Meraz ML; Cuellar-Herrera M Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555823 [TBL] [Abstract][Full Text] [Related]
12. Pharmacology of cannabinoids in the treatment of epilepsy. Gaston TE; Friedman D Epilepsy Behav; 2017 May; 70(Pt B):313-318. PubMed ID: 28087250 [TBL] [Abstract][Full Text] [Related]
13. Lipid Regulation of Sodium Channels. D'Avanzo N Curr Top Membr; 2016; 78():353-407. PubMed ID: 27586290 [TBL] [Abstract][Full Text] [Related]
14. Overview of cannabidiol (CBD) and its analogues: Structures, biological activities, and neuroprotective mechanisms in epilepsy and Alzheimer's disease. Li H; Liu Y; Tian D; Tian L; Ju X; Qi L; Wang Y; Liang C Eur J Med Chem; 2020 Apr; 192():112163. PubMed ID: 32109623 [TBL] [Abstract][Full Text] [Related]
15. Diversity of molecular targets and signaling pathways for CBD. de Almeida DL; Devi LA Pharmacol Res Perspect; 2020 Dec; 8(6):e00682. PubMed ID: 33169541 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection. Rosenberg EC; Patra PH; Whalley BJ Epilepsy Behav; 2017 May; 70(Pt B):319-327. PubMed ID: 28190698 [TBL] [Abstract][Full Text] [Related]
17. Modulation of Astrocyte Activity by Cannabidiol, a Nonpsychoactive Cannabinoid. Kozela E; Juknat A; Vogel Z Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28788104 [TBL] [Abstract][Full Text] [Related]
18. Beyond Pain Relief: A Review on Cannabidiol Potential in Medical Therapies. Luz-Veiga M; Azevedo-Silva J; Fernandes JC Pharmaceuticals (Basel); 2023 Jan; 16(2):. PubMed ID: 37259306 [TBL] [Abstract][Full Text] [Related]
19. Cannabidiol for Pain Treatment: Focus on Pharmacology and Mechanism of Action. Mlost J; Bryk M; Starowicz K Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33238607 [TBL] [Abstract][Full Text] [Related]